174 related articles for article (PubMed ID: 23763620)
1. In vivo and in silico pharmacokinetics and biodistribution of a melanocortin receptor 1 targeted agent in preclinical models of melanoma.
Tafreshi NK; Silva A; Estrella VC; McCardle TW; Chen T; Jeune-Smith Y; Lloyd MC; Enkemann SA; Smalley KS; Sondak VK; Vagner J; Morse DL
Mol Pharm; 2013 Aug; 10(8):3175-85. PubMed ID: 23763620
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and characterization of a melanoma-targeted fluorescence imaging probe by conjugation of a melanocortin 1 receptor (MC1R) specific ligand.
Tafreshi NK; Huang X; Moberg VE; Barkey NM; Sondak VK; Tian H; Morse DL; Vagner J
Bioconjug Chem; 2012 Dec; 23(12):2451-9. PubMed ID: 23116461
[TBL] [Abstract][Full Text] [Related]
3. 64Cu-labeled alpha-melanocyte-stimulating hormone analog for microPET imaging of melanocortin 1 receptor expression.
Cheng Z; Xiong Z; Subbarayan M; Chen X; Gambhir SS
Bioconjug Chem; 2007; 18(3):765-72. PubMed ID: 17348700
[TBL] [Abstract][Full Text] [Related]
4. Melanocortin 1 Receptor-Targeted α-Particle Therapy for Metastatic Uveal Melanoma.
Tafreshi NK; Tichacek CJ; Pandya DN; Doligalski ML; Budzevich MM; Kil H; Bhatt NB; Kock ND; Messina JL; Ruiz EE; Delva NC; Weaver A; Gibbons WR; Boulware DC; Khushalani NI; El-Haddad G; Triozzi PL; Moros EG; McLaughlin ML; Wadas TJ; Morse DL
J Nucl Med; 2019 Aug; 60(8):1124-1133. PubMed ID: 30733316
[TBL] [Abstract][Full Text] [Related]
5. PET of malignant melanoma using 18F-labeled metallopeptides.
Ren G; Liu Z; Miao Z; Liu H; Subbarayan M; Chin FT; Zhang L; Gambhir SS; Cheng Z
J Nucl Med; 2009 Nov; 50(11):1865-72. PubMed ID: 19837749
[TBL] [Abstract][Full Text] [Related]
6. Biodistribution and Multicompartment Pharmacokinetic Analysis of a Targeted α Particle Therapy.
Tichacek CJ; Tafreshi NK; Kil H; Engelman RW; Doligalski ML; Budzevich MM; Gage KL; McLaughlin ML; Wadas TJ; Silva A; Moros E; Morse DL
Mol Pharm; 2020 Nov; 17(11):4180-4188. PubMed ID: 32960613
[TBL] [Abstract][Full Text] [Related]
7. Radiofluorinated rhenium cyclized α-MSH analogues for PET imaging of melanocortin receptor 1.
Ren G; Liu S; Liu H; Miao Z; Cheng Z
Bioconjug Chem; 2010 Dec; 21(12):2355-60. PubMed ID: 21073170
[TBL] [Abstract][Full Text] [Related]
8. Small-animal PET of melanocortin 1 receptor expression using a 18F-labeled alpha-melanocyte-stimulating hormone analog.
Cheng Z; Zhang L; Graves E; Xiong Z; Dandekar M; Chen X; Gambhir SS
J Nucl Med; 2007 Jun; 48(6):987-94. PubMed ID: 17504880
[TBL] [Abstract][Full Text] [Related]
9. Melanoma Imaging Using
Zhang C; Zhang Z; Lin KS; Lau J; Zeisler J; Colpo N; Perrin DM; Bénard F
Mol Pharm; 2018 Jun; 15(6):2116-2122. PubMed ID: 29714486
[TBL] [Abstract][Full Text] [Related]
10. Microdistribution of MC1R-targeted polyplexes in murine melanoma tumor tissue.
Durymanov MO; Slastnikova TA; Kuzmich AI; Khramtsov YV; Ulasov AV; Rosenkranz AA; Egorov SY; Sverdlov ED; Sobolev AS
Biomaterials; 2013 Dec; 34(38):10209-16. PubMed ID: 24075405
[TBL] [Abstract][Full Text] [Related]
11.
Yang J; Xu J; Gonzalez R; Lindner T; Kratochwil C; Miao Y
Sci Transl Med; 2018 Nov; 10(466):. PubMed ID: 30404861
[TBL] [Abstract][Full Text] [Related]
12. Glycosylated DOTA-alpha-melanocyte-stimulating hormone analogues for melanoma targeting: influence of the site of glycosylation on in vivo biodistribution.
Bapst JP; Calame M; Tanner H; Eberle AN
Bioconjug Chem; 2009 May; 20(5):984-93. PubMed ID: 19388674
[TBL] [Abstract][Full Text] [Related]
13. Development of melanoma-targeted polymer micelles by conjugation of a melanocortin 1 receptor (MC1R) specific ligand.
Barkey NM; Tafreshi NK; Josan JS; De Silva CR; Sill KN; Hruby VJ; Gillies RJ; Morse DL; Vagner J
J Med Chem; 2011 Dec; 54(23):8078-84. PubMed ID: 22011200
[TBL] [Abstract][Full Text] [Related]
14. Increasing molar activity by HPLC purification improves 68Ga-DOTA-NAPamide tumor accumulation in a B16/F1 melanoma xenograft model.
von Hacht JL; Erdmann S; Niederstadt L; Prasad S; Wagener A; Exner S; Beindorff N; Brenner W; Grötzinger C
PLoS One; 2019; 14(6):e0217883. PubMed ID: 31163066
[TBL] [Abstract][Full Text] [Related]
15. Melanocortin 1 receptor regulates melanoma cell migration by controlling syndecan-2 expression.
Chung H; Lee JH; Jeong D; Han IO; Oh ES
J Biol Chem; 2012 Jun; 287(23):19326-35. PubMed ID: 22493442
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the human melanoma targeting properties of radiolabeled alpha-melanocyte stimulating hormone peptide analogues.
Miao Y; Whitener D; Feng W; Owen NK; Chen J; Quinn TP
Bioconjug Chem; 2003; 14(6):1177-84. PubMed ID: 14624632
[TBL] [Abstract][Full Text] [Related]
17. Preclinical Melanoma Imaging with
Zhang C; Zhang Z; Lin KS; Pan J; Dude I; Hundal-Jabal N; Colpo N; Bénard F
Theranostics; 2017; 7(4):805-813. PubMed ID: 28382155
[TBL] [Abstract][Full Text] [Related]
18. 203Pb-labeled alpha-melanocyte-stimulating hormone peptide as an imaging probe for melanoma detection.
Miao Y; Figueroa SD; Fisher DR; Moore HA; Testa RF; Hoffman TJ; Quinn TP
J Nucl Med; 2008 May; 49(5):823-9. PubMed ID: 18413404
[TBL] [Abstract][Full Text] [Related]
19. Malignant melanoma and melanocortin 1 receptor.
Rosenkranz AA; Slastnikova TA; Durymanov MO; Sobolev AS
Biochemistry (Mosc); 2013 Nov; 78(11):1228-37. PubMed ID: 24460937
[TBL] [Abstract][Full Text] [Related]
20. Melanocortin-1 receptor-targeting with radiolabeled cyclic α-melanocyte-stimulating hormone analogs for melanoma imaging.
Raposinho PD; Correia JD; Oliveira MC; Santos I
Biopolymers; 2010; 94(6):820-9. PubMed ID: 20564045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
